Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Side Effects Litigation
The Firm is currently investigating Pradaxa lawsuits on behalf of individuals who allegedly suffered serious internal bleeding, a potentially life-threatening Pradaxa side effect.
New York, New York (PRWEB) June 15, 2013
Hundreds of Pradaxa lawsuit claims continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to court documents, the Court held a Status Conference on June 10th, at which time issues involving witness depositions were addressed. The Court has scheduled the Pradaxa side effect litigation´s next Status Conference for July 9, 2013. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation — MDL No. 2385)
“We are pleased to see that progress continues in this litigation. Our Firm continues to receive inquiries from patients who used this blood thinner, and allegedly suffered serious Pradaxa side effects associated with life-threatening internal bleeding,”says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Pradaxa side effect claims evaluations to patients who have suffered serious internal bleeding, allegedly due to this drug.
Pradaxa Side Effects
Court filings indicate that 1,075 Pradaxa side effects lawsuits are currently pending in the Southern District of Missouri. All of the lawsuits allege use of the blood thinner caused plaintiffs to suffer from life-threatening episodes of Pradaxa bleeding, and accuse Boehringer Ingelheim of failing to adequately warn that there was no readily-available antidote for the serious internal bleeding that can sometimes accompany use of the drug.
Pradaxa is a blood thinner that was approved by the U.S. Food & Drug Administration (FDA) in October 2010, and is used to prevent strokes in people suffering from atrial fibrillation.
According to a Bloomberg.com report from December 2012, several government regulators have issued warnings regarding Pradaxa side effects, especially its association with life-threatening internal bleeding. * The Institute for Safe Medicine Practices also recently reported that its analysis of hemorrhage cases reported to the FDA during the second quarter of 2012 found that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding.**
Alleged victims of Pradaxa side effects may be entitled to compensation for their medical bills, lost wages, pain and suffering and more. Additional information on filing a Pradaxa lawsuit is available at Bernstein Liebhard LLP´s website. To arrange for a free legal consultation, please call 800-511-5092.
**Bloomberg, December 11, 2012; bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html
***ISMP, January 9, 2013; ismp.org/quarterwatch/pdfs/2012Q2.pdf
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs´ Hot List,” recognizing the top plaintiffs´ firms in the country, for the past 10 consecutive years
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebpradaxa-lawsuit/pradaxa-side-effects/prweb10837535.htm